✦ LIBER ✦

744 TENOFOVIR DF (TDF) IS SAFE AND WELL TOLERATED IN CHRONIC HEPATITIS B (CHB) PATIENTS WITH PRE-EXISTING MILD RENAL IMPAIRMENT

✍ Scribed by Fung, S.; Kwan, P.; Horban, A.; Pelemis, M.; Husa, P.; Hann, H.W.; Flaherty, J.; Massetto, B.; Dinh, P.; Custodio, J.; Subramanian, G.M.; Fabri, M.; Gane, E.

Book ID: 122857832
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 78 KB
Volume: 58
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(13)60746-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

531 TENOFOVIR DF TREATMENT IS SAFE AND W

531 TENOFOVIR DF TREATMENT IS SAFE AND WELL TOLERATED IN CHRONIC HEPATITIS B (CHB) PATIENTS WITH BASELINE DECREASED GLOMERULAR FILTRATION RATE

✍ P. Marcellin; F. Zoulim; X. Causse; C. Hézode; D. Larrey; G. Pageaux; B. Roche; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Immunization with a DNA vaccine candidat

Immunization with a DNA vaccine candidate in chronic hepatitis C patients is safe, well tolerated and does not impair immune response induction after anti-hepatitis B vaccination

✍ Marlen Castellanos; Zurina Cinza; Zaily Dorta; Gloria Veliz; Héctor Vega; Irma L 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

## Abstract ## Background In the present study, we evaluated the safety of CIGB‐230, a novel vaccine candidate based on the mixture of a plasmid for DNA immunization, expressing hepatitis C virus (HCV) structural antigens, with a recombinant HCV Core protein. ## Methods Fifteen HCV chronically‐i